Drug Discovery in the Field of β-Lactams: An Academic Perspective
β-Lactams are the most widely prescribed class of antibiotics that inhibit penicillin-binding proteins (PBPs), particularly transpeptidases that function in peptidoglycan synthesis. A major mechanism of antibiotic resistance is the production of β-lactamase enzymes, which are capable of hydrolyzing...
Saved in:
Main Authors: | Lian M. C. Jacobs (Author), Patrick Consol (Author), Yu Chen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory
by: Carmella Russo, et al.
Published: (2023) -
β-Lactam Antibiotics Renaissance
by: Wenling Qin, et al.
Published: (2014) -
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
by: Giacomo Luci, et al.
Published: (2021) -
Decrease of Antimicrobial Resistance through Polyelectrolyte-Coated Nanoliposomes Loaded with β-Lactam Drug
by: Lina M. Arévalo, et al.
Published: (2018) -
Non-<i>β</i>-Lactam Allosteric Inhibitors Target Methicillin-Resistant <i>Staphylococcus aureus</i>: An <i>In Silico</i> Drug Discovery Study
by: Mahmoud A. A. Ibrahim, et al.
Published: (2021)